跳至主要内容
临床试验/EUCTR2007-000008-34-GB
EUCTR2007-000008-34-GB进行中(未招募)不适用

Bacteria and host immune response as factors modulating visceral afferent processing in Irritable Bowel Syndrome: manipulation of visceral hypersensitivity with probiotic bacteria

orth West London Hospitals NHS Trust0 个研究点目标入组 10 人开始时间: 2007年5月30日最近更新:
适应症
相关药物

试验速览

阶段
不适用
状态
进行中(未招募)
发起方
入组人数
10

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • The inclusion criteria are:
  • Patients fulfilling the Rome II criteria for the diagnosis of IBS
  • Normal blood investigations (FBC, ESR, CRP, LFT, RCF, Ferritin, Vitamin B12)
  • Normal colonoscopy.
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range

排除标准

  • The exclusion criteria will be:
  • A history of weight loss
  • Rectal bleeding
  • Psychiatric illness (severe depression, anxiety, mania and schizophrenia)
  • Active infection
  • Recent antibiotic therapy or anti-inflammatory medication within previous 4 weeks

研究者

发起方
orth West London Hospitals NHS Trust

相似试验